Updated:
A&E Medical Corporation
A&E Medical Corporation no longer operates independently; its thoracic portfolio was absorbed into Zimmer Biomet.
A&E Medical Corporation
A&E Medical Corporation’s web presence no longer reflects an independent operating entity. All attempts to reach the firm’s former corporate site resolve to a Zimmer Biomet product portal focused on chest wall stability solutions. The URL aemedical.com serves as a marketing and product education hub for the THORACICSTRONG portfolio, which encompasses Sternal Closure, Rib Fixation, Cardiovascular, and Pectus Repair categories. Zimmer Biomet completed its $38 billion merger in 2015 and subsequently folded thoracic-focused acquisitions like A&E Medical into its broader musculoskeletal platform. The thoracic portfolio now marketed via aemedical.com includes rigid sternal fixation systems like SternaLock Blu and SternaLock XP, rib fixation systems including RibFix Blu and RibFix Advantage, and the Pectus Blu system for minimally invasive pectus excavatum repair. Ancillary cardiovascular products such as temporary pacing wires and rotating surgical punches are also part of the suite. Clinical evidence cited on the site references sternal healing randomized controlled trials and specific studies supporting SternaLock 360 and SternaLock Blu, with Japanese regulatory approval secured in the 2012–2015 period. No separate executive leadership, headcount, or financials for A&E Medical Corporation are publicly disclosed as of 2026. The site identifies no standalone management team; all branding and product narratives attribute the work to Zimmer Biomet’s CMFT (Cardiothoracic, CMF & Thoracic) team. The absence of an independent entity means any prior family-office or institutional allocation to A&E Medical Corporation has been extinguished or converted into a position in Zimmer Biomet Holdings common equity. For institutional allocators seeking exposure to the thoracic medical device subsegment, the only accessible vehicle today is the parent company, Zimmer Biomet Holdings (NYSE: ZBH). The absorption into a publicly traded, $24 billion market-cap orthopedics platform eliminates the structural differentiator of a private, specialized device manufacturer. Any prior investment thesis tied to A&E Medical’s specific operational profile or management team should be considered closed.
General information
Firm type
Asset Manager
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Farmingdale
Corporate office
Farmingdale, United States
Sector focus
Frequently asked questions
Does A&E Medical Corporation still exist as an independent entity?
No. The domain aemedical.com resolves to a Zimmer Biomet product page, and no separate corporate entity, leadership team, or financial disclosures for A&E Medical Corporation are publicly available as of 2026. The firm's thoracic product lines have been fully absorbed into Zimmer Biomet’s operating divisions.
What happened to the legacy A&E Medical product portfolio?
The portfolio — including SternaLock sternal closure systems, RibFix rib fixation plates, and Pectus Blu pectus repair bars — is now marketed as Zimmer Biomet’s THORACICSTRONG suite under its CMFT team. Ancillary cardiovascular devices such as temporary pacing wires are also part of the offering.
Can an institutional allocator still invest directly in A&E Medical Corporation?
No. Any prior private investment in A&E Medical has been extinguished or converted into a position in Zimmer Biomet Holdings, which trades on the New York Stock Exchange under the ticker ZBH. There is no remaining privately held vehicle for the thoracic business.
How does Zimmer Biomet’s thoracic business relate to A&E Medical’s original focus?
Zimmer Biomet’s thoracic product line, accessed through aemedical.com, directly continues A&E Medical’s work in chest wall stabilization. The product categories — sternal closure, rib fixation, and pectus repair — map exactly to A&E Medical’s legacy offerings, now integrated with Zimmer Biomet’s larger musculoskeletal portfolio and clinical research infrastructure.
Is A&E Medical Corporation a family office or allocator searching entity?
A&E Medical Corporation was a medical device manufacturer, not a family office, asset manager, or institutional allocator. Its profile is now entirely subsumed into Zimmer Biomet, a publicly traded orthopedics company, making it irrelevant for direct alternative investment allocation.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: